Doctor profile · Federal record
Dr. SIRINTORN MANN, PA-C
Physician Assistant · DANVILLE, CA
- NPI 1982608576
- Accepts Medicare
- MIPS 93.6 / 100 · 2023
- 24 yrs in practice
- Female
- No sanctions
Practice & contact
- Primary practice
-
907 SAN RAMON VALLEY BLVD, STE 202
DANVILLE, CA 945264036
(925) 837-4202
fax (925) 838-3224
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- March 7, 2023
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- California #PA16643
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1982608576. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,133
Distinct HCPCS
9
Medicare allowed
$86,609
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,380 | 14 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 306 | 166 | $123 | |
83036 |
Hemoglobin a1c level | 169 | 100 | $10 | |
J3489 |
Injection, zoledronic acid, 1 mg | 73 | 15 | $9 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 66 | 53 | $88 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 64 | 37 | $33 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 32 | 32 | $164 | |
96372 |
Injection of drug or substance under skin or into muscle | 29 | 17 | $15 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 14 | 14 | $73 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 237. This provider delivers 9.0× the peer median.Open Payments
Industry payments received
All-time total
$202
Transactions
10
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 2 | $35.30 | |
| Lilly USA, LLC | 2 | $33.85 | |
| Radius Health, Inc. | 1 | $30.74 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22.38 | |
| Xeris Pharmaceuticals, Inc. | 1 | $21.23 | |
| Dexcom, Inc. | 1 | $20.55 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $20.51 | |
| Abbott Laboratories | 1 | $17.77 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,455
Patients
453
Total drug cost
$1,028,959
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 194 | 49 | $317,103 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 160 | 46 | $3,197 |
| Levothyroxine Sodium | Generic | 158 | 45 | $3,167 |
| Jardiance (Empagliflozin) | Brand | 156 | 43 | $238,661 |
| Metformin Hcl | Generic | 138 | 40 | $2,282 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 107 | 42 | $109,433 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 76 | 34 | $9,106 |
| Glipizide | Generic | 70 | 24 | $1,947 |
| Trulicity (Dulaglutide) | Brand | 68 | 18 | $125,012 |
| Atorvastatin Calcium | Generic | 65 | 19 | $670 |